The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant, 2025Analysis of 18F-DPA714 Dynamic Data with Arterial Sampling Obtained at UAB
Study Rationale: The study will analyze clinical PET data from 5 subjects imaged dynamically with 18F-DPA714, an imaging larker for brain inflammation. The purpose of the study is to ensure that...
-
Research Grant, 2025Analysis of a Potential Alpha-synuclein PET Tracer (18F-FD4) in HC, PD and MSA
Study Rationale: 18F-FD4 is a new imaging agent that has the potential to image alpha-synuclein in the living human brain with Positron Emission Tomography (PET). Given alpha-synuclein’s central role...
-
Circuits & Cellular Targets for PD’s Symptoms, 2025Role of B2*-Nicotinic Receptors in Parkinson’s Disease Related Circuits and Symptoms
Study Rationale: One pathological hallmark of Parkinson’s disease (PD) is the degeneration of dopamine neurons innervating the striatum. Dopamine loss is associated with several adaptive changes in...
-
MRI Biomarkers Program, 2025Molecular MRI Correlates of Parkinsonian Neurodegeneration
Study Rationale: New imaging tools for Parkinson’s disease (PD) are urgently needed to help accelerate the development of new treatments. A special type of MRI scan, CEST MRI, can detect changes in...
-
MRI Biomarkers Program, 2025Validate Diffusion MRI Biomarkers of Early PD: A Multi-cohort Study of Free-water and CDM Measure
Study Rationale: Parkinson’s disease and related synucleinopathies, such as Dementia with Lewy Bodies, are challenging to diagnose at their earliest stages due to subtle initial symptoms. Our research...
-
MRI Biomarkers Program, 2025Evaluation of Neuromelanin-sensitive, Quantitative Susceptibility Mapping and Free Water Imaging as Biomarkers of Nigral Dopaminergic Dysfunction
Study Rationale: This project seeks to validate three magnetic resonance imaging biomarkers capable of detecting and monitoring the degeneration of neurons in the substantia nigra in Parkinson’s...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.